NSD2 and metabolic dysfunction-associated steatohepatitis: DNA methylation alterations occurring under the conditions of NASH participated in NASH-related multistage hepatocarcinogenesis through aberrant expression of specific tumor-related genes, such as WHSC1 [11], TRIM4, PRC1 and TUBA1B [12].